Metraipolis › archive › dc_338a2ba1583c

Soluble CTLA-4 and high-risk genetic variants: A new frontier in pancreatic ductal adenocarcinoma (PDAC) biomarkers — Europe PMC PMID:41141615

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41141615
DOI
10.1016/j.bbrep.2025.102304
License (as archived)
solo-consultazione
Archived
2026-11-09T08:06:36.524Z
SHA-256 of the archived text
6008caf9f7a8bf9a3ccc922481aaa359e3fe982f1c9e51f1f5220a69ce6fd152
Stable URL of this page
https://metraipolis.com/documento/dc_338a2ba1583c

How to cite

Soluble CTLA-4 and high-risk genetic variants: A new frontier in pancreatic ductal adenocarcinoma (PDAC) biomarkers — Europe PMC PMID:41141615 — Europe PMC (en), https://europepmc.org/article/MED/41141615 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_338a2ba1583c (Metraipolis archive dc_338a2ba1583c, sha256 6008caf9f7a8bf9a3ccc922481aaa359e3fe982f1c9e51f1f5220a69ce6fd152)
BibTeX
@misc{dc338a2ba1583c,
  title = {Soluble CTLA-4 and high-risk genetic variants: A new frontier in pancreatic ductal adenocarcinoma (PDAC) biomarkers — Europe PMC PMID:41141615},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41141615},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_338a2ba1583c; sha256 6008caf9f7a8bf9a3ccc922481aaa359e3fe982f1c9e51f1f5220a69ce6fd152},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41141615. Agents can read the archived copy with the MCP tool read_document.